Global B2B Pharmaceutical Marketplace · Sourcing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Factor VIII Concentrate powder bulk supplier for pharma manufacturers

Factor Viii Concentrate Powder Suppliers & Bulk Manufacturers

Available Forms: Lyophilized (freeze-dried) powder

Available Strengths: 250 IU, 500 IU, 1000 IU, 2000 IU vials

Reference Brands: Hemofil M, Kogenate FS, Advate(US); Kogenate, Octanate, Lonoctocog alfa(EU)

Category: Blood Disorder

Factor VIII concentrates are replacements for missing or defective clotting factor VIII in hemophilia A. They help restore normal blood clotting, reduce bleeding episodes, and prevent hemorrhages. Benefits include improved bleeding control, enhanced joint health, and increased quality of life for hemophilia patients, reducing bleeding-related complications.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Factor VIII concentrates are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA regulates these products, while the EMA oversees approval in the EU. Dossiers include clinical trial data, stability, and pharmacovigilance information. These concentrates are essential for hemophilia A management, used to prevent and treat bleeding episodes. Both regions require rigorous evaluation before market authorization. For detailed regulatory insights, licensing requirements, and approved dossiers for Factor VIII concentrates, visit Pharmatradz. Stay updated on global regulatory standards and market access pathways for hemophilia treatments.

Factor Viii Concentrate Powder — third party manufacturing & bulk supply

Factor Viii Concentrate Powder is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Factor Viii Concentrate Powder listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Factor Viii Concentrate Powder →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Factor VIII Concentrate powder is used to treat and prevent bleeding episodes in patients with hemophilia A, a genetic bleeding disorder caused by a deficiency of clotting Factor VIII. It is also used to control bleeding during surgeries or injuries in patients with this condition.

Factor VIII Concentrate powder is produced either from purified human plasma or through recombinant DNA technology. It contains coagulation Factor VIII, a protein that plays a vital role in the blood clotting process.

Common trade names include Advate, Adynovate, Eloctate, Afstyla, Kovaltry, and NovoEight.

Factor VIII Concentrate products are manufactured by several pharmaceutical companies including Takeda, Bayer, CSL Behring, Novo Nordisk, Sanofi, and Pfizer depending on the specific brand.

The generic name is coagulation factor VIII or antihemophilic factor (recombinant).

Brand names include Advate (USA, EU, India, LATAM), Adynovate (USA, EU), Eloctate (USA, EU, global markets), Afstyla (USA, EU), Kovaltry (USA, EU, LATAM), and NovoEight (USA, EU, global markets).

Factor VIII Concentrate powder is manufactured in several countries including the United States, Germany, Denmark, Austria, and other European countries depending on the manufacturer and brand.

Related Products

Anagrelide Hydrochloride

Strength:
0.5 mg

Form: Capsules

Reference Brands: Agrylin (USA)

View Details
Ferric Maltol

Strength:
30 mg

Form: Capsules

Reference Brands: Accrufer (USA), Feraccru (EU)

View Details
Lusutrombopag

Strength:
3 mg

Form: Tablets

Reference Brands: Mulpleta (USA), Mulpleo (EU)

View Details
Avatrombopag Maleate

Strength:
20mg

Form: Tablets

Reference Brands: Doptelet (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.